Combination Study for High Risk Multiple Myeloma Patients
Public ClinicalTrials.gov record NCT03104270. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Trial of the Efficacy and Safety of Elotuzumab in Combination With Pomalidomide, Carfilzomib and Dexamethasone Among High Risk Relapsed/ Refractory Multiple Myeloma Patients
Study identification
- NCT ID
- NCT03104270
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Oncotherapeutics
- Industry
- Enrollment
- 13 participants
Conditions and interventions
Conditions
Interventions
- Elotuzumab Drug
- Pomalidomide Drug
- Carfilzomib Drug
- Dexamethasone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 12, 2017
- Primary completion
- Oct 24, 2019
- Completion
- Jan 22, 2020
- Last update posted
- Mar 30, 2022
2017 – 2020
United States locations
- U.S. sites
- 6
- U.S. states
- 3
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Cancer Associates for Research & Excellence (cCARE) | Encinitas | California | 92024 | — |
| Robert A. Moss, MD, FACP, Inc | Fountain Valley | California | 92708 | — |
| Pacific Cancer Care | Monterey | California | 93940 | — |
| James Berenson, MD, Inc | West Hollywood | California | 90069 | — |
| Millennium Oncology Research Clinic | Pembroke Pines | Florida | 33024 | — |
| Regional Cancer Care Associates MD LLC | Bethesda | Maryland | 20817 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03104270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03104270 live on ClinicalTrials.gov.